| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | |||||
The ESMO Immuno-Oncology Congress 2025 will be held from 10 to 12 December 2025 as a hybrid event, both onsite in London, UK, and online. This leading international congress brings together experts from around the globe to explore the full spectrum of immuno-oncology from basic science and translational research to clinical advancements. Attendees can expect cutting-edge sessions, in-depth learning opportunities, and dynamic networking with peers, researchers, and industry leaders.
The programme includes immersion sessions focused on immunobiology and translational insights, updates on checkpoint inhibitor-based therapies, and the latest in immune modulation including tumour microenvironment, immunometabolism, and cell signaling. Participants will also engage with industry and independent investigators to explore developments in cellular therapies, cancer vaccines, intratumoural immunotherapy, and multispecific constructs.
Whether attending in person or online, the congress offers a valuable platform to share research, expand knowledge, and shape the future of cancer immunotherapy.
Registration is Open for the Event.
More posts featuring ESMO.
